Oncology PracticeChemotherapy better for metastatic breast cancer maintenance than durvalumabDecember 20, 2019Breast Cancer
New evidence informs discussions on FL treatment and breast screeningDecember 20, 2019Follicular LymphomaBreast CancerPatient & Survivor Care
Oncology PracticeOral paclitaxel bests IV version for tumor response, neuropathy incidence in mBCDecember 19, 2019Breast Cancer
Oncology PracticePEARL lacks luster in metastatic breast cancer progressing on AIsDecember 18, 2019Breast Cancer
Oncology PracticeTNBC: Weekly nab-paclitaxel delivers, denosumab disappointsDecember 17, 2019Breast Cancer
Oncology PracticeFirst report from NeoTRIPaPDL1: No pCR benefit with atezolizumab in TNBCDecember 16, 2019Breast Cancer
Oncology PracticeCTS5 score partially validated for predicting late distant breast cancer recurrencesDecember 16, 2019Breast Cancer
Oncology PracticeTNBC: Adding capecitabine boosts disease-free survival in prospective trialDecember 13, 2019Breast Cancer
Oncology PracticePembrolizumab plus chemo boosts pCR rate in TNBCDecember 13, 2019Breast CancerImmuno-oncology
Oncology PracticePromising new neoadjuvant strategy in luminal B breast cancerDecember 13, 2019Breast Cancer
Oncology PracticeAPHINITY 6-year data: Benefit ongoing in HER2+ early BC, no significant OS benefitDecember 12, 2019Breast Cancer
Oncology PracticeCapecitabine extends survival in triple-negative breast cancerDecember 12, 2019Breast Cancer
